16 Cervix Carcinoma

362 Cervix Cancer

92. Pernot M, Hoffstetter S, Peiffert D, et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment. Bull Cancer 1995; 82(7) : 568-81. 93. Petereit DG, Sarkaria JN, Potter DM, et al. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience. Int J Radiat Oncol Biol Phy 1999; 45 : 1267-74. 94. Petereit DG, Pearcey R Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999; 43 : 359-66. 95. Pierquin B, Marinello G, Mege JP, Crook J. Intracavitary irradiation of carcinomas of the uterus and cervix: the Creteil method. Int J Radiat Oncol Biol Phys 1988; 15 (6) : 1465-73. 96. Pötter R, Knocke TH, Fellner C, et al. Definitive radiotherapy based on HDR brachytherapy with Iridum-192 in cervix cancer – report on the recent Vienna University Hospital experience (1993-1997) compared to the preceding period, referring to ICRU 38 recommendations. Bull Cancer Radiother 2000; 4 : 159-172. 97. Pötter R, Van Limbergen E, Gerstner N, et al. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001; 58 :1-4. 98. Pourquier H, Delard R, Achiulle E, et al. A quantified approach of the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 1987; 13 : 1025-33. 99. Riou G, Favre M, Jeannel D, et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990; 335 (8699) : 1171-4. 100. Rodrigus P, De Winter K, Venselaar JLM, et al. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol 1997; 42 : 137- 41. 101. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995; 274 : 387-93. 102. Rotte K (1980) A randomised clinical trial comparing a high-dose rate with a conventional dose-rate technique. In Berry RJ (ed): Br J Radiol 1980; (Special report) 17 : 75-79. 103. Rubin P, Constine LS, Fajardo LF, et al. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995; 31 (5) : 1041-2. 104. San Filippo N, de Crevoisier R, Kafrouni H, at al. Three dimensional assessment of applicator movement in brachytherapy for cervical carcinoma. Radiother Oncol 2001; 60 : 23. 105. Selke P, Roman TN, Souhami L, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993; 27 : 803-9. 106. Shigematsu Y, Nishiyama K, Masaki N, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose-rate: a comparative study with a low-dose-rate system . Int J Radiat Oncol Biol Phys 1983; 9 : 351-6. 107. Sinistero G, Sismondi P, Rumore A, et al. Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary. Radiother Oncol 1993; 26 : 203-21. 108. Stitt JA, Fowler JF, Thomadsen BR, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992; 24 : 335-48. 109. Symonds RP. How the laboratory can help the clinician improve cure rates in invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1992; 1 : 313-7. 110. Tan LT, Jones B, Gee A, et al. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique. Br J Radiol 1997; 70 : 1259-69. 111. Teshima T, Chatani M, Hata K, Inoue T. High-Dose rate and Low-Dose Rate intracavitary therapy for carcinoma of the uterine cervix: Final Results of Osaka University Hospital. Cancer 1993; 72 : 2409-14.